- Home
- DLHC vs COYA Comparison
DLHC vs COYA Comparison
Compare DLHC & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLHC
- COYA
- Stock Information
- Founded
- DLHC 1969
- COYA 2020
- Country
- DLHC United States
- COYA United States
- Employees
- DLHC N/A
- COYA N/A
- Industry
- DLHC Business Services
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- DLHC Consumer Discretionary
- COYA Health Care
- Exchange
- DLHC Nasdaq
- COYA Nasdaq
- Market Cap
- DLHC 117.4M
- COYA 104.3M
- IPO Year
- DLHC N/A
- COYA 2022
- Fundamental
- Price
- DLHC $8.53
- COYA $6.50
- Analyst Decision
- DLHC
- COYA Strong Buy
- Analyst Count
- DLHC 0
- COYA 3
- Target Price
- DLHC N/A
- COYA $16.67
- AVG Volume (30 Days)
- DLHC 55.7K
- COYA 138.0K
- Earning Date
- DLHC 12-04-2024
- COYA 11-06-2024
- Dividend Yield
- DLHC N/A
- COYA N/A
- EPS Growth
- DLHC N/A
- COYA N/A
- EPS
- DLHC 0.17
- COYA N/A
- Revenue
- DLHC $401,038,000.00
- COYA $9,554,315.00
- Revenue This Year
- DLHC $8.70
- COYA N/A
- Revenue Next Year
- DLHC $6.10
- COYA $54.20
- P/E Ratio
- DLHC $48.90
- COYA N/A
- Revenue Growth
- DLHC 17.39
- COYA N/A
- 52 Week Low
- DLHC $7.94
- COYA $4.75
- 52 Week High
- DLHC $17.58
- COYA $10.69
- Technical
- Relative Strength Index (RSI)
- DLHC 47.54
- COYA 44.11
- Support Level
- DLHC $8.18
- COYA $5.90
- Resistance Level
- DLHC $8.62
- COYA $7.50
- Average True Range (ATR)
- DLHC 0.36
- COYA 0.50
- MACD
- DLHC 0.01
- COYA -0.12
- Stochastic Oscillator
- DLHC 35.98
- COYA 36.36
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. It is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, and telehealth systems.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.